Idarubicin hydrochloride
CAS No. 57852-57-0
Idarubicin hydrochloride ( 4-Demethoxydaunorubicin hydrochloride )
Catalog No. M15119 CAS No. 57852-57-0
An anthracycline antileukemic that inserts into DNA and prevents DNA unwinding by interfering with the enzyme Topoisomerase II in cancer cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 50 | In Stock |
|
10MG | 87 | In Stock |
|
25MG | 147 | In Stock |
|
100MG | Get Quote | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameIdarubicin hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionAn anthracycline antileukemic that inserts into DNA and prevents DNA unwinding by interfering with the enzyme Topoisomerase II in cancer cells.
-
DescriptionAn anthracycline antileukemic that inserts into DNA and prevents DNA unwinding by interfering with the enzyme Topoisomerase II in cancer cells; inhibits the proliferation of MCF-7 cells with IC50 of 0.1 uM; also induces histone eviction from chromatin.Chemotherapeutic Agents Approved
-
Synonyms4-Demethoxydaunorubicin hydrochloride
-
PathwayCell Cycle/DNA Damage
-
TargetTopoisomerase
-
RecptorMulticellular spheroids; Topo II (MCF-7 cells)
-
Research AreaCancer
-
IndicationChemotherapeutic
Chemical Information
-
CAS Number57852-57-0
-
Formula Weight533.95
-
Molecular FormulaC26H28ClNO9
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESO=C1C2=C(O)C([C@@H](O[C@H]3C[C@H](N)[C@H](O)[C@H](C)O3)C[C@](O)(C(C)=O)C4)=C4C(O)=C2C(C5=C1C=CC=C5)=O.[H]Cl
-
Chemical Name5,12-Naphthacenedione, 9-acetyl-7-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-, hydrochloride (1:1), (7S,9S)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Gewirtz DA, et al. Cancer Chemother Pharmacol. 1998;41(5):361-9.
2. Pang B, et al. Nat Commun. 2013;4:1908.
3. Nitiss JL. Nat Rev Cancer. 2009 May;9(5):338-50.
2. Pang B, et al. Nat Commun. 2013;4:1908.
3. Nitiss JL. Nat Rev Cancer. 2009 May;9(5):338-50.
molnova catalog
related products
-
Doxorubicin hydrochl...
Doxorubicin (Adriamycin) is an antibiotic agent that inhibits DNA topoisomerase II and induces DNA damage and apoptosis.
-
Doxorubicin
Doxorubicin is an Anthracycline Topoisomerase Inhibitor.
-
9-Aminocamptothecin
9-Aminocamptothecin is an inhibitor of topoisomerase I with potent anticancer activity.